EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis
RM Ransohoff - Trends in immunology, 2006 - cell.com
Trends in immunology, 2006•cell.com
1 Bedoui, S. et al.(2004) More sympathy for autoimmunity with neuropeptide Y? Trends
Immunol. 25, 508–512 2 Steinman, L.(2004) Elaborate interactions between the immune
and nervous systems. Nat. Immunol. 5, 575–581 3 Lachenecker, P. et al.(2001) Autonomic
dysfunction in multiple sclerosis is related to disease activity and progression of disability.
Mult. Scler. 7, 327–334 4 Mapp, PI et al.(1990) Substance P-, calcitonin gene-related
peptideand C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in …
Immunol. 25, 508–512 2 Steinman, L.(2004) Elaborate interactions between the immune
and nervous systems. Nat. Immunol. 5, 575–581 3 Lachenecker, P. et al.(2001) Autonomic
dysfunction in multiple sclerosis is related to disease activity and progression of disability.
Mult. Scler. 7, 327–334 4 Mapp, PI et al.(1990) Substance P-, calcitonin gene-related
peptideand C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in …
1 Bedoui, S. et al.(2004) More sympathy for autoimmunity with neuropeptide Y? Trends Immunol. 25, 508–512 2 Steinman, L.(2004) Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5, 575–581 3 Lachenecker, P. et al.(2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult. Scler. 7, 327–334
4 Mapp, PI et al.(1990) Substance P-, calcitonin gene-related peptideand C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 37, 143–153 5 Kawamura, N. et al.(1998) Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5, 9–15
cell.com
